MedTrace Logo

HRQOL in Prostate Cancer Patients Treated With Radiotherapy

NCT05645237 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-08-19

No results posted yet for this study

Summary

The study primarily aims at evaluating health-related quality of life after radiotherapy for prostate cancer, using modern hypofractionated radiotherapy schedules. Study design is a prospective observational cohort study. All patients give written informed consent and fill out online validated questionnaires before, during, and after radiotherapy (yearly) up to 5 years post-treatment.

Conditions

Interventions

RADIATION

radiotherapy

Radiotherapy is delivered with linear accelerators or cyberknife (external beam radiotherapy), or local irradiation with high dose rate brachytherapy (brachytherapy)

Sponsors & Collaborators

Principal Investigators

  • Luca Incrocci, MD PhD · Erasmus Medical Center

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-08
Primary Completion
2027-06-01
Completion
2030-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05645237 on ClinicalTrials.gov